Sanofi Aktie
80,87
EUR
-0,07
EUR
-0,09
%
81,99
EUR
+0,56
EUR
+0,69
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Jefferies & Company Inc. | 100,00 EUR | +21,97% | 26.03.2026 | |
| Deutsche Bank AG | 100,00 EUR | +21,97% | 26.03.2026 | |
| JP Morgan Chase & Co. | 95,00 EUR | +15,87% | 25.03.2026 | |
| Barclays Capital | 85,00 EUR | +3,67% | 25.03.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 105,00 EUR | +28,06% | 20.03.2026 | |
| Goldman Sachs Group Inc. | 89,00 EUR | +8,55% | 30.01.2026 | |
| UBS AG | 88,00 EUR | +7,33% | 29.01.2026 | |
| Bernstein Research | 119,00 EUR | +45,14% | 05.12.2025 | |
| DZ BANK | - | - | 24.10.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 7 | 1 | 1 | 141,80 GBP | - |
| Bayer | 5 | 4 | 1 | 39,67 EUR | +3,60% |
| BioNTech (ADRs) | 4 | 1 | 0 | 136,40 USD | +59,20% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 1 | 0 | 8,07 EUR | +87,50% |
| GSK PLC Registered Shs | 2 | 5 | 2 | 20,24 GBP | -1,22% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 3 | 0 | 140,50 EUR | +33,68% |
| Moderna Inc | 0 | 0 | 0 | - | - |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -1,90% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +4,77% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | +19,06% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |